R115777 in Treating Patients Who Have Metastatic Pancreatic Cancer
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Phase II trial to study the effectiveness of R115777 in treating patients who have metastatic
pancreatic cancer. Drugs used in chemotherapy use different ways to stop tumor cells from
dividing so they stop growing or die.